Benchmarking European Investigator Payments

Report Overview

This report provides an analysis of Europe’s clinical trial compensation for investigator payments across 18 therapeutic areas, 5 compound types, and the 4 phases of development.  It provides pharmaceutical, biotech, and service providers an opportunity to gain a better understanding of what drives investigator payments so they can benchmark their payment levels and better plan for study costs.

What you will learn:

• Average compensation investigators receive per subject for each therapy area by phase and compound orientation/ type
• How study characteristics (length and complexity) change fee levels
• What motivates investigators to participate in a trial
• Therapeutic area profiles

How you can use this report:

• Optimize your investigator payments across therapeutic areas, phases of development, compound type under investigation, and geography
• Establish and better negotiate investigator payments
• Use “trial complexity” and “length of study” as variables to create more accurate budget projections and lower costs

Methodology:

ISR conducted 142 online quantitative surveys with respondents who:

• Currently work at a research site
• Are located in Western or Eastern Europe
• Have responsibility for investigator payments